Carcinoma thyroid duplex- coexistence of papillary thyroid carcinoma with thyroid lymphoma: A case report and literature review
DOI:
https://doi.org/10.5457/ams.v51i1-2.620Keywords:
Malignant tumor, Papillary thyroid carcinoma, Thyroid limphomaAbstract
Background: Malignant tumors of the thyroid gland accounts about 1% of the newly diagnosed malignant tumors each year, and their incidence in women is twice the incidence in men. Papillary thyroid cancer (PTC) represents 80-85% of thyroid cancer and its prevalence has been rising in the last decades. On the contrary, primary thyroid lymphoma (PTL) is a rare disease, accounting for 3% of extranodal lymphomas and about 5% of thyroid malignancis. Despite several cases in witch both PTC and PTL arise in the setting of chronic lymphocyte thyreoiditis, the coexistence of both tumors is very rare.
The aim was to present a patient with a primary thyroid lymphoma and papillary thyroid carcinoma, who had previously not had any immunological changes to the gland, that is, she had not had any chronic lymphocyte thyroiditis, but due to the compressive syndrome it was necessary to perform an emergency surgical procedure to reduce the tumor.
Conclusion: Considering the higher risk of neoplasia in Haschimoto's thyreoiditis with long-standing disease and nodular lesions, our case highlights the importance of regular folow-up in order to reach an early diagnosis: in particular, a sudden tharoid enlargement in elder patients should lead physicians to consider PTL in the differential diagnosis.
Downloads
Published
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
